Medicine
Efavirenz 600 mg tablet
Efavirenz 600 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Efavirenz tablets, USP should be stored at 25°C (77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Efavirenz
- Brand
- Sold under the generic name
- Strength
- 600 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 3 blister pack, 30 tablets, 250 tablets and 5 more
- Manufacturers
- Aurobindo PharmaIndiaCamber PharmaceuticalsIndiaCiplaIndiaMacleods PharmaceuticalsIndiaXLCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Efavirenz tablets, USP should be stored at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AG03 Efavirenz
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 April 2018
- Identifiers
- RxCUI 349477DailyMed set ID 966b815d-1d78-4b54-8f00-c5a0b67c78be, 13ca3456-e5bf-4bb1-af95-b1378658a358, c5eedb5d-4cab-4056-a14a-ffdf67701355 +2NDC 72865-172, 33342-013, 65862-049 +2Application ANDA078886, ANDA091579, ANDA077673 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-049-10 | Aurobindo PharmaIndia | 21 September 2018 |
| 30 tablet, film coated in 1 bottle | 65862-049-30 | Aurobindo PharmaIndia | 21 September 2018 |
| 250 tablet, film coated in 1 bottle | 31722-504-25 | Camber PharmaceuticalsIndia | 27 April 2018 |
| 30 tablet, film coated in 1 bottle | 31722-504-30 | Camber PharmaceuticalsIndia | 27 April 2018 |
| 30 tablet, film coated in 1 bottle | 69097-301-02 | CiplaIndia | 18 June 2018 |
| 30 tablet in 1 bottle | 33342-013-07 | Macleods PharmaceuticalsIndia | 10 May 2024 |
| 250 tablet, film coated in 1 bottle | 72865-172-25 | XLCare Pharmaceuticals | 29 May 2021 |
| 30 tablet, film coated in 1 bottle | 72865-172-30 | XLCare Pharmaceuticals | 29 May 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Efavirenz
Clinical summary
Efavirenz is a human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, among other approved uses. MedsAcross supplies Efavirenz for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EfavirenzFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Efavirenz prescribing information (Macleods Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Efavirenz Teva: European public assessment report (EPAR) · European Medicines Agency
Need Efavirenz 600 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.